Delivery Order SPE2DB25D7068-SPE2DB25FTYBT
- Not listed
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Citalopram HBR 20 mg tablets (500 count) with a ceiling value of $16,986.60. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a competitively awarded, non-set-aside contract executed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $1,023.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 tablets) on September 8, 2025, with an ultimate completion date of September 9, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 10 mg tablets (500 count) valued at $46,580.81 under a firm fixed-price contract. This competitively awarded delivery order, with no set-aside designation, was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,329.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies the place of performance as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $17,210.57 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.19 to AmerisourceBergen Drug Corp for 500 tablets of Citalopram HBR 20 mg, with a completion date of September 24, 2025. This is a firm fixed-price delivery order issued without a set-aside designation, reflecting a competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a $6,948.25 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Citalopram HBr 20 mg tablets (500 count). This competitive award utilizes firm fixed pricing with a completion date of September 8, 2025, and represents a non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Citalopram HBr 20 mg tablets (500 count) valued at $1,582.47. This firm fixed-price delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,501.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets in quantities of 500 units. This firm fixed price delivery order, issued on September 25, 2025, represents a non-competitive award under an existing contract vehicle and is scheduled for ultimate completion by September 26, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Citalopram HBR 40 mg tablets (500-count units) with a ceiling value of $12,406.14. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and a critical vendor for federal medical procurement,...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYBTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,356.67 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets in quantities of 500 units. This firm fixed-price, competitively awarded delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's DLA IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a prime contractor holding significant federal contract awards across multiple therapeutic domains—including neurological treatments, pain management pharmaceuticals, antibiotics, and specialty medications—AmerisourceBergen has demonstrated the capability to meet federal procurement requirements through open competition and continues to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 9/19/25 |